Purchase Order 75N95025P00408

Award Date 9/24/25
Potential Completion Date 9/23/26
Potential Value $696K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This purchase order for $282,527.04 was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Revvity Health Sciences, Inc. for the maintenance of five PerkinElmer Operetta and Opera Phenix laboratory instruments located in Potomac, Maryland. The non-competitive solicitation sought renewal of an annual maintenance agreement for the instruments, requiring comprehensive maintenance, calibration, and repair...
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for annual preventative maintenance services on its existing Operetta CLS' and Opera Phenix automated imaging systems. The $530,109.36 contract has a period of performance from April 26, 2024 to April 25, 2025. This is a non-competitive, commercial services acquisition...
This firm fixed price purchase order for $207,890.40 was awarded by the National Institutes of Health's National Institute of Environmental Health Sciences to Revvity Health Sciences, Inc. for preventive maintenance of a PerkinElmer Opera Phenix Plus system. The system will support chemical screening efforts at the research facility located in Research Triangle Park, North Carolina over a three year period of performance from December 2022 through December 2024. As the sole source manufacturer...
This is a firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for a maintenance agreement for an Opera Phenix high-content imaging system. The contract has a 2-year period of performance with a ceiling value of $183,648. This award was not set aside for any specific business type. Revvity is a for-profit manufacturer that provides a wide range...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for a preventative maintenance agreement on four PerkinElmer Operetta systems. The one-year contract, valued at $90,912.00, will provide unlimited repair visits, PerkinElmer certified parts, training discounts, and priority response for the systems located at the NIH's Integrated Research...
This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, part of the National Institutes of Health, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $365,598.51, is to provide a service protection plan to ensure that critical research instruments are always available and in good working condition for the agency's research staff. The contract has a completion date of November 29, 2024, and does not include any...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for maintenance service of the OPERA high-throughput microscopy system. The contract has a ceiling value of $84,827.60 and a completion date of September 22, 2017. The contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that provides various medical...
This is a $18,290 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The service agreement has an ultimate completion date of January 11, 2026. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products and equipment. The company has previously received prime contracts, subcontracts, and indefinite delivery vehicle awards from federal agencies like the NIH, CDC,...
This federal contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $178,361.58, is for the maintenance and service of high-throughput microscopy, automated image plate loading/unloading, and liquid handling equipment. This is a firm fixed-price purchase order contract with a period of performance from August 2015 to August 2016. The...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), for crating, packing, unpacking, and re-installing the Revvity Opera Phenix. The total ceiling value of the contract is $20,281.50, and the ultimate completion date is January 31, 2025. There is no set-aside designation for this award. Revvity Health Sciences, Inc. is a for-profit manufacturer that...

This is a sole-source contract awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $696,235.12 to provide preventative maintenance and repair services on specialized scientific instrumentation. The contract covers one Operetta CLS system, six Opera Phenix systems, one Flex 750 plate handler, and one Robot Fixed Cell unit that are critical for NCATS' translational research. Revvity is the sole authorized provider to service this equipment. The contract has a 12-month base period from September 2025 to September 2026, with two 12-month option periods. This is a firm fixed-price purchase order with no set-aside designation, indicating Revvity's ability to compete as a large business. The contract showcases Revvity's expertise in providing advanced scientific equipment and support to federal agencies.

Generated 9/27/25, 9:50 AM